Moderate

Secondary hypertension - endocrine screening

2ndary HTN · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Structured evaluation for a hormonal cause of hypertension, prompted by resistant, early-onset, or hypokalaemic hypertension. Identifying a curable endocrine cause can resolve or markedly improve blood pressure.

Red flags

  • Hypertensive emergency with end-organ damage
  • Paroxysmal headache/palpitations/sweating (phaeochromocytoma)
  • Severe spontaneous hypokalaemia
  • Rapidly progressive or malignant hypertension
  • Young patient with severe hypertension and a family history

Assessment

Differential diagnosis

  • Primary aldosteronism
  • Phaeochromocytoma/paraganglioma
  • Cushing syndrome
  • Thyroid dysfunction
  • Renal artery stenosis/renal parenchymal disease
  • Obstructive sleep apnoea
  • Drug-induced hypertension

Investigations

  • Aldosterone-to-renin ratio (ideally off interfering drugs)
  • Plasma/24h urinary metanephrines
  • 1 mg overnight dexamethasone suppression test if Cushing suspected
  • TSH, U&E (hypokalaemia) and renal imaging as indicated
  • Confirmatory tests (saline suppression, adrenal imaging, adrenal vein sampling) per positive screen

Management

  • Identify who to screen: resistant, early-onset (<40), severe, or hypokalaemic hypertension and incidentaloma
  • Review drugs and lifestyle factors raising blood pressure
  • Screen for primary aldosteronism with aldosterone-to-renin ratio in appropriate patients
  • Screen for phaeochromocytoma with metanephrines if paroxysmal symptoms or incidentaloma
  • Screen for Cushing if clinical features present
  • Check thyroid function and consider renovascular and sleep apnoea assessment
  • Confirm positive screens with definitive testing before intervention
  • Localise with adrenal imaging and, for aldosteronism, adrenal vein sampling if surgery considered
  • Treat the specific cause (surgery, mineralocorticoid antagonist, etc.)
  • Continue general antihypertensive and cardiovascular risk management

Drugs & doses

Spironolactone 25-50 mg or eplerenone PO for confirmed primary aldosteronism (medical arm)
Alpha-blockade before phaeochromocytoma surgery
Standard antihypertensives (avoiding those that invalidate ARR where feasible)
Cause-specific therapy after confirmation

Disposition

Investigate via primary care/hypertension clinic with endocrinology referral for confirmatory testing; refer surgically correctable causes to specialist centres.

Complications & pitfalls

  • Accelerated cardiovascular and renal damage if untreated
  • Phaeochromocytoma crisis
  • Missed curable cause with lifelong unnecessary polypharmacy
  • Electrolyte disturbances

Exam pearls

  • Primary aldosteronism is far commoner than historically thought; screen all resistant/hypokalaemic hypertension
  • Many antihypertensives distort the aldosterone-to-renin ratio, so interpret carefully or adjust drugs
  • Normal potassium does not exclude primary aldosteronism
  • Always exclude phaeochromocytoma before adrenal surgery for any cause

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.